The PD1 inhibitory pathway and mature dendritic cells contribute to abacavir hypersensitivity in human leukocyte antigen transgenic PD1 knockout mice
•Abacavir-induced severe skin hypersensitivity could be reproduced in mice.•PD1 knockout facilitated Abacavir-induced CD8 T cell activation.•CD4 T cell depletion could promote sufficient DC maturation.•PD1 knockout and CD4 T cell depletion could lead to CD8 T cells proliferation. Based on recent gen...
Gespeichert in:
Veröffentlicht in: | Toxicology (Amsterdam) 2021-11, Vol.463, p.152971-152971, Article 152971 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 152971 |
---|---|
container_issue | |
container_start_page | 152971 |
container_title | Toxicology (Amsterdam) |
container_volume | 463 |
creator | Song, Binbin Aoki, Shigeki Liu, Cong Susukida, Takeshi Kuwahara, Saki Ito, Kousei |
description | •Abacavir-induced severe skin hypersensitivity could be reproduced in mice.•PD1 knockout facilitated Abacavir-induced CD8 T cell activation.•CD4 T cell depletion could promote sufficient DC maturation.•PD1 knockout and CD4 T cell depletion could lead to CD8 T cells proliferation.
Based on recent genome-wide association studies, abacavir-induced hypersensitivity is highly associated with human leukocyte antigen (HLA)-B*57:01 allele. However, the underlying mechanism of this occurrence is unclear. To investigate the underlying mechanism, we developed HLA-B*57:01 transgenic mice and found that application of abacavir could cause CD8 T cell activation with elevation in PD1 expression; however, severe skin hypersensitivity was not observed. To eliminate the immunosuppressive effect of PD1, HLA-B*57:01 transgenic/PD1 knockout (01Tg/PD1) mice were generated by mating HLA-B*57:01 transgenic mice and PD1 knockout mice. Thereafter, 01Tg/PD1 mice were treated with abacavir. Similar to the above results, severe skin hypersensitivity was not observed. Therefore, we treated 01Tg/PD1 mice with an anti-CD4 antibody to deplete CD4 T cells, followed by abacavir topically and orally. Severe abacavir-induced skin hypersensitivity was observed in 01Tg/PD1 mice after depletion of CD4 T cells, in addition to significant CD8 T cell activation and dendritic cell maturation. Taken together, we succeeded in reproducing severe skin hypersensitivity in a mouse model. And we found that through the combined depletion of PD1 and CD4 T cells, CD8 T cells could be activated and could proceed to clonal proliferation, which is promoted by mature dendritic cells, thereby eventually inducing severe skin hypersensitivity. |
doi_str_mv | 10.1016/j.tox.2021.152971 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2579378650</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0300483X21002936</els_id><sourcerecordid>2579378650</sourcerecordid><originalsourceid>FETCH-LOGICAL-c419t-f9ed91bf2a178a23fd2473a4f681bb04d7bdafb135b5af7b7691bb0b96303bb33</originalsourceid><addsrcrecordid>eNp9kctu1DAUhi0EokPhAdggL9lksOMkjsUKlatUqV20EjvLlxPimYk92M5AHoT3xdEUlt34WNZ3PuucH6HXlGwpod273TaH39ua1HRL21pw-gRtaM9FxWjfPkUbwgipmp59v0AvUtoRQmrWdM_RRTlJJ1q2QX_uRsC3Hyl2fnTa5RAXfFR5_KUWrLzFk8pzBGzB2-iyM9jA4ZCwCT5Hp-cMOAestDLq5CIelyPEBD4V9OTyUqx4nCfl8QHmfTBL4ZXP7gd4nKPyqVyKc_1_74PZhznjyRl4iZ4N6pDg1UO9RPefP91dfa2ub758u_pwXZmGilwNAqygeqgV5b2q2WDrhjPVDF1PtSaN5dqqQVPW6lYNXPNOrO9adIwwrRm7RG_P3mMMP2dIWU4urRMqD2FOsm65YLzvWlJQekZNDClFGOQxuknFRVIi1zTkTpY05JqGPKdRet486Gc9gf3f8W_9BXh_BqAMeXIQZTIOvAHrIpgsbXCP6P8CuCiesQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2579378650</pqid></control><display><type>article</type><title>The PD1 inhibitory pathway and mature dendritic cells contribute to abacavir hypersensitivity in human leukocyte antigen transgenic PD1 knockout mice</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Song, Binbin ; Aoki, Shigeki ; Liu, Cong ; Susukida, Takeshi ; Kuwahara, Saki ; Ito, Kousei</creator><creatorcontrib>Song, Binbin ; Aoki, Shigeki ; Liu, Cong ; Susukida, Takeshi ; Kuwahara, Saki ; Ito, Kousei</creatorcontrib><description>•Abacavir-induced severe skin hypersensitivity could be reproduced in mice.•PD1 knockout facilitated Abacavir-induced CD8 T cell activation.•CD4 T cell depletion could promote sufficient DC maturation.•PD1 knockout and CD4 T cell depletion could lead to CD8 T cells proliferation.
Based on recent genome-wide association studies, abacavir-induced hypersensitivity is highly associated with human leukocyte antigen (HLA)-B*57:01 allele. However, the underlying mechanism of this occurrence is unclear. To investigate the underlying mechanism, we developed HLA-B*57:01 transgenic mice and found that application of abacavir could cause CD8 T cell activation with elevation in PD1 expression; however, severe skin hypersensitivity was not observed. To eliminate the immunosuppressive effect of PD1, HLA-B*57:01 transgenic/PD1 knockout (01Tg/PD1) mice were generated by mating HLA-B*57:01 transgenic mice and PD1 knockout mice. Thereafter, 01Tg/PD1 mice were treated with abacavir. Similar to the above results, severe skin hypersensitivity was not observed. Therefore, we treated 01Tg/PD1 mice with an anti-CD4 antibody to deplete CD4 T cells, followed by abacavir topically and orally. Severe abacavir-induced skin hypersensitivity was observed in 01Tg/PD1 mice after depletion of CD4 T cells, in addition to significant CD8 T cell activation and dendritic cell maturation. Taken together, we succeeded in reproducing severe skin hypersensitivity in a mouse model. And we found that through the combined depletion of PD1 and CD4 T cells, CD8 T cells could be activated and could proceed to clonal proliferation, which is promoted by mature dendritic cells, thereby eventually inducing severe skin hypersensitivity.</description><identifier>ISSN: 0300-483X</identifier><identifier>EISSN: 1879-3185</identifier><identifier>DOI: 10.1016/j.tox.2021.152971</identifier><identifier>PMID: 34606953</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Animals ; Anti-HIV Agents - administration & dosage ; Anti-HIV Agents - immunology ; Anti-HIV Agents - toxicity ; CD4 T cell depletion ; CD8-Positive T-Lymphocytes - immunology ; Dendritic Cells - immunology ; Dideoxynucleosides - administration & dosage ; Dideoxynucleosides - immunology ; Dideoxynucleosides - toxicity ; Disease Models, Animal ; Drug Eruptions - immunology ; Drug Hypersensitivity - immunology ; HLA-B Antigens - immunology ; Humanized mice ; Idiosyncratic adverse drug reactions ; Immune suppression ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Mice, Transgenic ; Programmed Cell Death 1 Receptor - genetics ; Skin damage ; T cell reactivity</subject><ispartof>Toxicology (Amsterdam), 2021-11, Vol.463, p.152971-152971, Article 152971</ispartof><rights>2021 Elsevier B.V.</rights><rights>Copyright © 2021 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c419t-f9ed91bf2a178a23fd2473a4f681bb04d7bdafb135b5af7b7691bb0b96303bb33</citedby><cites>FETCH-LOGICAL-c419t-f9ed91bf2a178a23fd2473a4f681bb04d7bdafb135b5af7b7691bb0b96303bb33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0300483X21002936$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34606953$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Song, Binbin</creatorcontrib><creatorcontrib>Aoki, Shigeki</creatorcontrib><creatorcontrib>Liu, Cong</creatorcontrib><creatorcontrib>Susukida, Takeshi</creatorcontrib><creatorcontrib>Kuwahara, Saki</creatorcontrib><creatorcontrib>Ito, Kousei</creatorcontrib><title>The PD1 inhibitory pathway and mature dendritic cells contribute to abacavir hypersensitivity in human leukocyte antigen transgenic PD1 knockout mice</title><title>Toxicology (Amsterdam)</title><addtitle>Toxicology</addtitle><description>•Abacavir-induced severe skin hypersensitivity could be reproduced in mice.•PD1 knockout facilitated Abacavir-induced CD8 T cell activation.•CD4 T cell depletion could promote sufficient DC maturation.•PD1 knockout and CD4 T cell depletion could lead to CD8 T cells proliferation.
Based on recent genome-wide association studies, abacavir-induced hypersensitivity is highly associated with human leukocyte antigen (HLA)-B*57:01 allele. However, the underlying mechanism of this occurrence is unclear. To investigate the underlying mechanism, we developed HLA-B*57:01 transgenic mice and found that application of abacavir could cause CD8 T cell activation with elevation in PD1 expression; however, severe skin hypersensitivity was not observed. To eliminate the immunosuppressive effect of PD1, HLA-B*57:01 transgenic/PD1 knockout (01Tg/PD1) mice were generated by mating HLA-B*57:01 transgenic mice and PD1 knockout mice. Thereafter, 01Tg/PD1 mice were treated with abacavir. Similar to the above results, severe skin hypersensitivity was not observed. Therefore, we treated 01Tg/PD1 mice with an anti-CD4 antibody to deplete CD4 T cells, followed by abacavir topically and orally. Severe abacavir-induced skin hypersensitivity was observed in 01Tg/PD1 mice after depletion of CD4 T cells, in addition to significant CD8 T cell activation and dendritic cell maturation. Taken together, we succeeded in reproducing severe skin hypersensitivity in a mouse model. And we found that through the combined depletion of PD1 and CD4 T cells, CD8 T cells could be activated and could proceed to clonal proliferation, which is promoted by mature dendritic cells, thereby eventually inducing severe skin hypersensitivity.</description><subject>Animals</subject><subject>Anti-HIV Agents - administration & dosage</subject><subject>Anti-HIV Agents - immunology</subject><subject>Anti-HIV Agents - toxicity</subject><subject>CD4 T cell depletion</subject><subject>CD8-Positive T-Lymphocytes - immunology</subject><subject>Dendritic Cells - immunology</subject><subject>Dideoxynucleosides - administration & dosage</subject><subject>Dideoxynucleosides - immunology</subject><subject>Dideoxynucleosides - toxicity</subject><subject>Disease Models, Animal</subject><subject>Drug Eruptions - immunology</subject><subject>Drug Hypersensitivity - immunology</subject><subject>HLA-B Antigens - immunology</subject><subject>Humanized mice</subject><subject>Idiosyncratic adverse drug reactions</subject><subject>Immune suppression</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Mice, Transgenic</subject><subject>Programmed Cell Death 1 Receptor - genetics</subject><subject>Skin damage</subject><subject>T cell reactivity</subject><issn>0300-483X</issn><issn>1879-3185</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kctu1DAUhi0EokPhAdggL9lksOMkjsUKlatUqV20EjvLlxPimYk92M5AHoT3xdEUlt34WNZ3PuucH6HXlGwpod273TaH39ua1HRL21pw-gRtaM9FxWjfPkUbwgipmp59v0AvUtoRQmrWdM_RRTlJJ1q2QX_uRsC3Hyl2fnTa5RAXfFR5_KUWrLzFk8pzBGzB2-iyM9jA4ZCwCT5Hp-cMOAestDLq5CIelyPEBD4V9OTyUqx4nCfl8QHmfTBL4ZXP7gd4nKPyqVyKc_1_74PZhznjyRl4iZ4N6pDg1UO9RPefP91dfa2ub758u_pwXZmGilwNAqygeqgV5b2q2WDrhjPVDF1PtSaN5dqqQVPW6lYNXPNOrO9adIwwrRm7RG_P3mMMP2dIWU4urRMqD2FOsm65YLzvWlJQekZNDClFGOQxuknFRVIi1zTkTpY05JqGPKdRet486Gc9gf3f8W_9BXh_BqAMeXIQZTIOvAHrIpgsbXCP6P8CuCiesQ</recordid><startdate>202111</startdate><enddate>202111</enddate><creator>Song, Binbin</creator><creator>Aoki, Shigeki</creator><creator>Liu, Cong</creator><creator>Susukida, Takeshi</creator><creator>Kuwahara, Saki</creator><creator>Ito, Kousei</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202111</creationdate><title>The PD1 inhibitory pathway and mature dendritic cells contribute to abacavir hypersensitivity in human leukocyte antigen transgenic PD1 knockout mice</title><author>Song, Binbin ; Aoki, Shigeki ; Liu, Cong ; Susukida, Takeshi ; Kuwahara, Saki ; Ito, Kousei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c419t-f9ed91bf2a178a23fd2473a4f681bb04d7bdafb135b5af7b7691bb0b96303bb33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animals</topic><topic>Anti-HIV Agents - administration & dosage</topic><topic>Anti-HIV Agents - immunology</topic><topic>Anti-HIV Agents - toxicity</topic><topic>CD4 T cell depletion</topic><topic>CD8-Positive T-Lymphocytes - immunology</topic><topic>Dendritic Cells - immunology</topic><topic>Dideoxynucleosides - administration & dosage</topic><topic>Dideoxynucleosides - immunology</topic><topic>Dideoxynucleosides - toxicity</topic><topic>Disease Models, Animal</topic><topic>Drug Eruptions - immunology</topic><topic>Drug Hypersensitivity - immunology</topic><topic>HLA-B Antigens - immunology</topic><topic>Humanized mice</topic><topic>Idiosyncratic adverse drug reactions</topic><topic>Immune suppression</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Mice, Transgenic</topic><topic>Programmed Cell Death 1 Receptor - genetics</topic><topic>Skin damage</topic><topic>T cell reactivity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Song, Binbin</creatorcontrib><creatorcontrib>Aoki, Shigeki</creatorcontrib><creatorcontrib>Liu, Cong</creatorcontrib><creatorcontrib>Susukida, Takeshi</creatorcontrib><creatorcontrib>Kuwahara, Saki</creatorcontrib><creatorcontrib>Ito, Kousei</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Toxicology (Amsterdam)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Song, Binbin</au><au>Aoki, Shigeki</au><au>Liu, Cong</au><au>Susukida, Takeshi</au><au>Kuwahara, Saki</au><au>Ito, Kousei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The PD1 inhibitory pathway and mature dendritic cells contribute to abacavir hypersensitivity in human leukocyte antigen transgenic PD1 knockout mice</atitle><jtitle>Toxicology (Amsterdam)</jtitle><addtitle>Toxicology</addtitle><date>2021-11</date><risdate>2021</risdate><volume>463</volume><spage>152971</spage><epage>152971</epage><pages>152971-152971</pages><artnum>152971</artnum><issn>0300-483X</issn><eissn>1879-3185</eissn><abstract>•Abacavir-induced severe skin hypersensitivity could be reproduced in mice.•PD1 knockout facilitated Abacavir-induced CD8 T cell activation.•CD4 T cell depletion could promote sufficient DC maturation.•PD1 knockout and CD4 T cell depletion could lead to CD8 T cells proliferation.
Based on recent genome-wide association studies, abacavir-induced hypersensitivity is highly associated with human leukocyte antigen (HLA)-B*57:01 allele. However, the underlying mechanism of this occurrence is unclear. To investigate the underlying mechanism, we developed HLA-B*57:01 transgenic mice and found that application of abacavir could cause CD8 T cell activation with elevation in PD1 expression; however, severe skin hypersensitivity was not observed. To eliminate the immunosuppressive effect of PD1, HLA-B*57:01 transgenic/PD1 knockout (01Tg/PD1) mice were generated by mating HLA-B*57:01 transgenic mice and PD1 knockout mice. Thereafter, 01Tg/PD1 mice were treated with abacavir. Similar to the above results, severe skin hypersensitivity was not observed. Therefore, we treated 01Tg/PD1 mice with an anti-CD4 antibody to deplete CD4 T cells, followed by abacavir topically and orally. Severe abacavir-induced skin hypersensitivity was observed in 01Tg/PD1 mice after depletion of CD4 T cells, in addition to significant CD8 T cell activation and dendritic cell maturation. Taken together, we succeeded in reproducing severe skin hypersensitivity in a mouse model. And we found that through the combined depletion of PD1 and CD4 T cells, CD8 T cells could be activated and could proceed to clonal proliferation, which is promoted by mature dendritic cells, thereby eventually inducing severe skin hypersensitivity.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>34606953</pmid><doi>10.1016/j.tox.2021.152971</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0300-483X |
ispartof | Toxicology (Amsterdam), 2021-11, Vol.463, p.152971-152971, Article 152971 |
issn | 0300-483X 1879-3185 |
language | eng |
recordid | cdi_proquest_miscellaneous_2579378650 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Animals Anti-HIV Agents - administration & dosage Anti-HIV Agents - immunology Anti-HIV Agents - toxicity CD4 T cell depletion CD8-Positive T-Lymphocytes - immunology Dendritic Cells - immunology Dideoxynucleosides - administration & dosage Dideoxynucleosides - immunology Dideoxynucleosides - toxicity Disease Models, Animal Drug Eruptions - immunology Drug Hypersensitivity - immunology HLA-B Antigens - immunology Humanized mice Idiosyncratic adverse drug reactions Immune suppression Male Mice Mice, Inbred C57BL Mice, Knockout Mice, Transgenic Programmed Cell Death 1 Receptor - genetics Skin damage T cell reactivity |
title | The PD1 inhibitory pathway and mature dendritic cells contribute to abacavir hypersensitivity in human leukocyte antigen transgenic PD1 knockout mice |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T16%3A26%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20PD1%20inhibitory%20pathway%20and%20mature%20dendritic%20cells%20contribute%20to%20abacavir%20hypersensitivity%20in%20human%20leukocyte%20antigen%20transgenic%20PD1%20knockout%20mice&rft.jtitle=Toxicology%20(Amsterdam)&rft.au=Song,%20Binbin&rft.date=2021-11&rft.volume=463&rft.spage=152971&rft.epage=152971&rft.pages=152971-152971&rft.artnum=152971&rft.issn=0300-483X&rft.eissn=1879-3185&rft_id=info:doi/10.1016/j.tox.2021.152971&rft_dat=%3Cproquest_cross%3E2579378650%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2579378650&rft_id=info:pmid/34606953&rft_els_id=S0300483X21002936&rfr_iscdi=true |